Zenarestat

FK-366 (zenarestat) is a potent aldose reductase inhibitor that prevents sorbitol accumulation in diabetic tissues, helping delay complications like neuropathy and cataracts. It has shown strong efficacy in animal models and early human trials, with oral dosing significantly reducing aldose reductase activity and serum uric acid levels. The directory classifies it as a discontinued API with a synthetic source/manufacturing origin. Other names for this substance include Fk 366 and Zenarestatum. Its PubChem CID is 5724.

CAS No 112733-06-9
Molecular Formula C17H11BrClFN2O4
Molecular Weight 441.60 g/mol
Synonyms 2-[3-[(4-bromo-2-fluorophenyl)methyl]-7-chloro-2,4-dioxoquinazolin-1-yl]acetic acid

Frequently Asked Questions